Biocryst Pharmaceuticals, Inc. · NASDAQ:BCRX

Sanders Machelle received 15,294 Biocryst Pharmaceuticals, Inc. shares as an award (Form 4)

Traded Jun 11, 2026 · Filed Jun 15, 2026

On Jun 11, 2026, Sanders Machelle (Director) received 15,294 Biocryst Pharmaceuticals, Inc. shares as an award, leaving 45,936 shares. Filed Jun 15, 2026 (Form 4).

Awarded
15,294 shares
Holding after
45,936 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 11, 2026Common StockAward15,29445,936Direct

Source

View original at SEC

Related